Zobrazeno 1 - 10
of 13
pro vyhledávání: '"D F, Kraemer"'
Publikováno v:
Journal of Perinatology. 38:71-74
Human milk (donor milk (DM) and/or maternal milk (MM)) feedings protect against late onset sepsis (LOS), necrotizing enterocolitis (NEC) and death. However, DM lacks many anti-infective components of MM. Therefore, we studied exclusive MM feedings to
Autor:
David C. Spencer, Paul Wang, Daniel M. Spielman, Kim J. Burchiel, J. Szumowski, D. F. Kraemer
Publikováno v:
Acta Neurologica Scandinavica. 112:6-12
Objectives – Magnetic resonance spectroscopic imaging (MRSI) may show circumscribed or extensive decreased brain N-acetyl aspartate (NAA)/creatine and phosphocreatine (Cr) in epilepsy patients. We compared temporal lobe MRSI in patients seizure-fre
Publikováno v:
Neonatologie Scan. :114-114
Publikováno v:
Pharmacoepidemiology and drug safety. 6(6)
A Treatment IND (TIND) is a mechanism available to the Food and Drug Administration (FDA) in the United States by which promising new drugs can be provided to patients with life-threatening illnesses. In many instances, the illness is life-threatenin
Autor:
L L, Muldoon, P, Varallyay, D F, Kraemer, G, Kiwic, K, Pinkston, S L, Walker-Rosenfeld, E A, Neuwelt
Publikováno v:
Neuropathology and applied neurobiology. 30(1)
Central nervous system (CNS) drainage may occur via connections to the vasculature, but in animal models up to 50% occurs via perivascular, perineural and primitive lymphatic drainage to cervical lymph nodes. We evaluated efflux of particles from the
Autor:
N D, Doolittle, L L, Muldoon, R E, Brummett, R M, Tyson, C, Lacy, J S, Bubalo, D F, Kraemer, M C, Heinrich, J A, Henry, E A, Neuwelt
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 7(3)
Carboplatin is effective in the treatment of malignant brain tumors. However, when administered in conjunction with osmotic opening of the blood-brain barrier (BBB), carboplatin is ototoxic. The purpose of this study was to determine whether delayed
Publikováno v:
The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique. 8(1)
To assess the cost effectiveness of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor therapy, particularly atorvastatin, in primary and secondary prevention of coronary artery disease (CAD) in Canada.A Markov model was developed in
Autor:
N D, Doolittle, M E, Miner, W A, Hall, T, Siegal, E, Jerome, E, Osztie, L D, McAllister, J S, Bubalo, D F, Kraemer, D, Fortin, R, Nixon, L L, Muldoon, E A, Neuwelt
Publikováno v:
Cancer. 88(3)
The aim of this study was to determine the safety and efficacy of intraarterial chemotherapy with osmotic opening of the blood-brain barrier (BBB) for the treatment of malignant brain tumors when administered across multiple centers.Patients with pri
Autor:
L D, McAllister, N D, Doolittle, P E, Guastadisegni, D F, Kraemer, C A, Lacy, J R, Crossen, E A, Neuwelt
Publikováno v:
Neurosurgery. 46(1)
Patients with non-acquired immunodeficiency syndrome-related primary central nervous system lymphomas have the potential to achieve durable complete responses without radiotherapy, with treatment using enhanced chemotherapy delivery with blood-brain
Publikováno v:
Journal of the American Medical Informatics Association. 9:89-90